Depressive and Anxiety Symptom Assessment in Adults with Polycystic Ovarian Syndrome

Abstract

Background. Polycystic ovarian syndrome (PCOS) is an endocrinopathic disorder commonly affecting women in the reproductive age. These women have a possibility of developing depression and anxiety due to biochemical changes, concerns regarding physical appearance, and social pressure from infertility. Thus, the connection between PCOS, anxiety, and depression has a possible impact on patients’ quality of life. This study is aimed at assessing depression and anxiety symptoms among PCOS patients and their association with different socioeconomic aspects. Methods. A cross-sectional study was conducted to assess depression and anxiety symptoms on 250 PCOS patients which were selected through consecutive sampling technique. Arabic versions of the HAM-A and HAM-D questionnaires were used alongside a demographic sheet to determine the socioeconomic and fertility status. Results. Prevalence of anxiety symptoms was reported among 100 (40%) of women and was found to be significantly higher in single women with a prevalence of 59 (48%) ( χ 2 = 5.8 , p value <0.01). Also, lower-income status and unemployment were associated with a significantly higher prevalence of anxiety 18 (67%) ( χ 2 = 10.3 , p value =0.03) and 71 (45%) ( χ 2 = 4.5 , p value =0.03) women, respectively. Depressive symptoms were reported among 122 (49%) participants. Conclusion. Single marital status, low income, and unemployment were predictors of anxiety. Tension was noted to be the most common anxiety symptom among participants while depressed mood and psychological anxiety were the most reported depressive symptoms. It is important to note the link between anxiety, PCOS, and depression when deciding treatment plans for affected women.

Anxiety and Depression in Women with Polycystic Ovary Syndrome

“…Over 60% of the control group confirmed that they had no anxiety, and only 4.5% reported severe anxiety. In a recently conducted study, only 6% of the women with PCOS had severe anxiety symptoms; the rest had mild or moderate symptoms [ 58 ].…”

[Retracted] Image Analysis of TVCDS in Infertile Patients with Polycystic Ovary Syndrome

“…Adebisi O. et al believed that at the present stage, patients in the treatment group were 26–34 years old, with an average age of (25.2 ± 3.2) years; menstruation lasted from 1 to 7 months, with a mean of (2.54 ± 1.25) months; control patients were 24–35 years old, with a mean age of (64.2 ± 3.2) years; menstrual cycles ranged from 1 to 6 months, with an average menstrual cycle of (4.25 ± 1.25) months [ 9 ]. Almeshari W. et al believed that the main symptoms and signs of the laboratory examination results of B-ultrasonography in the symptoms related to sparse ovulation or anovulation; the late menstruation is up to 501 cases, accounting for 96.72%; 171 cases (33.1%) suffered from infertility, 157 were amenorrhea cases (30.31%), and there were 52 cases (10.04) of irregular vaginal bleeding [ 10 ].…”

Effects of Fagonia indica on Letrozole-Induced Polycystic Ovarian Syndrome (PCOS) in Young Adult Female Rats

“…Overweight and obesity further complicate the situation by accelerating insulin resistance [ 2 ]. Moreover, PCOS is associated with different endocrine, metabolic, and reproductive traits including hyperandrogenism, hyperinsulinism, obesity, hyperlipidemia, type 2 diabetes mellitus, cardiovascular abnormalities, depression, anxiety, anovulation, oligo-ovulation, infertility, hirsutism, and acne [ 3 , 4 ]. This syndrome is so devastated that it can cause endometrial hyperplasia and subsequently the development of endometrial cancer [ 5 ].…”